Metlifecare says indicative bid too low

Metlifecare has rejected an indicative takeover offer of $6.50 a share as being too low after sounding out some of its major shareholders.The board said its internal valuation could be in excess of $8 a share, depending on the assumptions used.The indicative offer from an unnamed suitor came out of...

Read the full story at BusinessDesk — subscribe now: https://businessdesk.co.nz/article/metlifecare-says-indicative-bid-too-low

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

POT completes sale of Rolleston property asset
RAD - Radius Health to Release 1H27 Results on 11 November 2026
PCT Climate Related Disclosures 2026
SPN confirms FY26 result & provides leadership update
AGL - Accordant Group FY27 Half Year results
AIR - Air NZ to hold investor update
NZM - NZME receives offer for renewal of radio spectrum licences
October 28th Morning Report
ARG - FY27 interim results announcement date and webcast details
Devon Funds Morning Note - 27 October 2026